Blackstone Raises Record $6.3 Billion Life Sciences Fund to Back Pharma and Medtech Programs
Blackstone closed a $6.3 billion life sciences fund, the largest private fund of its kind, nearly 40% bigger than its previous vehicle. The fund targets late-stage drug and medtech development. Investor demand exceeded Blackstone’s target, closing the fund at its maximum size. Blackstone shares rose 3.3% in early trading Tuesday.